Development of the Eating Behaviour Lapse Inventory Survey Singapore (eBLISS):An Exploratory Mixed-method Study


An exploratory mixed-method study will be conducted to develop an instrument for early detection and prevention of overconsumption.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: March 22, 2023


  • Behavioral: eBLISS
    • a novel instrument -Eating Behaviour Lapse Inventory Survey Singapore (eBLISS)- will be developed

Clinical Trial Outcome Measures

Primary Measures

  • Self-regulation of Eating Behaviour Questionnaire (SREBQ)
    • Time Frame: 2021-2023

Participating in This Clinical Trial

Inclusion Criteria

1. Above the legal age of 21 years old 2. Have a BMI ≥ 23kg/m2 3. Able to understand and read English language 4. Uses a smart phone that can download apps 5. Able to provide informed consent Exclusion Criteria:

1. Diagnosed with a pre-existing psychological disorder such as anxiety and depression except binge eating disorder 2. Participating in a concurrent weight management intervention that is beside the usual care

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • National University Health System, Singapore
  • Collaborator
    • National University, Singapore
  • Provider of Information About this Clinical Study
    • Principal Investigator: Jocelyn Chew, Research Fellow – National University Health System, Singapore
  • Overall Contact(s)
    • Jocelyn Chew, PhD, +6565168687,

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.